37 matches for your search in the start-up spotlight
rss
Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 ...
Those Vegan Cowboys are on a mission to make the best cow-less milk and cheese. When you’re trying to watch the stars in the middle of the city, you’re gonna miss most of them. We took a step back into the old west where the stars at night shine big and bright and opened our eyes to new ...
atbtherapeutics is a pioneering biopharmaceutical company building a pipeline of weaponized antibodies. Those novel therapeutic formats can only be achieved using our proprietary plant-based atbiofarm technology.
4Tissue is a biotech company at the forefront of regenerative medicine, utilizing advanced bio-interactive hydrogels to transition from cells to tissue engineering. Founded through a collaboration between Prof. Phillip Blondeel, a global leader in plastic and reconstructive surgery, and Prof. Dr. ...
AmphiStar offers a portfolio of locally produced microbial biosurfactants to companies seeking to develop sustainable, performant & affordable products with surfactants as important performance ingredients. AmphiStars’ surfactants are part of a platform technology and are not linked to fossil ...
AmphiStar offers a portfolio of locally produced microbial biosurfactants to companies seeking to develop sustainable, performant & affordable products with surfactants as important performance ingredients. AmphiStars’ surfactants are part of a platform technology and are not linked to fossil ...
The world is facing an unprecedented antimicrobial resistance crisis with regular antibiotics losing their efficacy against antibiotic-resistant bacteria. Obulytix is a biotechnology company focused on the discovery and development of a groundbreaking class of enzyme-based antibiotics to combat ...
Amyl Therapeutics has developed a novel mechanism to conformationally bind to the amyloid fold of toxic protein aggregates of various types, causing neurodegenerative diseases or systemic amyloidosis diseases. The pan-amyloid binding and amyloid fibril remodeling capabilities of Amyl ...
Bioxodes specializes in the development of novel therapies for the prevention and treatment of thrombotic and inflammatory diseases. Since its founding in 2013, Bioxodes has developed its own flagship program based around its Ir-CPI molecule. Ir-CPI is a first-in-class drug candidate aimed at ...
Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure, and restore organ function. By combining new scientific insights with robust drug development and a long-term corporate vision, we are ...
